Tag: OSX

Osteopore ASX OSX European Patent 3D biomimetic scaffolds implant

Osteopore collars European patent for next generation bone regenerative implant technology

Osteopore’s (ASX: OSX) bone healing technology has reached another milestone after the European Patent Office granted a patent for the company’s next generation of regenerative implants. The patent...
Osteopore ASX OSX Terumo Blood and Cell Technologies

Osteopore reports consistent revenue growth and upscales global distribution

Osteopore (ASX: OSX) has updated the market with strong company performance figures, declaring it recorded four straight quarters of revenue growth last year including a $429,700 result in the 2020 fo...
Osteopore OSX ASX Australia Germany distribution agreement MTG Medizintechnik Göhl

Osteopore signs deal to distribute medical implant products through German and Austrian markets

Bone healing biotech Osteopore (ASX: OSX) has signed an exclusive two-year agreement with medical device distributor MTG Medizintechnik Göhl to promote and sell its products in Germany and Austria. ...
Osteopore former ResMed executive Carl Runde board ASX OSX

Osteopore adds former ResMed executive Carl Runde to its board

Osteopore (ASX: OSX) has boosted its board with the appointment of highly experienced and former ResMed (ASX: RMD) executive Carl Runde to the role of chief financial officer. According to Osteopor...
Osteopore ASX OSX Australia NZ distribution deal bone healing scaffolds

Osteopore inks Australia and NZ distribution deal for bone healing scaffolds

Bone healing biotech company Osteopore (ASX: OSX) has signed an exclusive deal with Australian-owned LMT Surgical to promote and sell its 3D-printed medical products within the Australian and New Zeal...
Osteopore sales 2020 September quarter ASX OSX

Osteopore shrugs off COVID-19 to report 40% revenue growth

Medical technology company Osteopore (ASX: OSX) revealed it experienced “encouraging sales growth” with quarterly revenue growing to over $408,000, despite challenges posed by COVID-19. The feat re...
Osteopore OSX ASX bioresorbable mandibular reconstruction technology National University of Singapore Hospital

Osteopore looks to expand its range of 3D-printed bioresorbable implants

Medical technology company Osteopore (ASX: OSX) has taken a step towards expanding its range of 3D-printed bioresorbable products by signing a research collaboration agreement with the National Univer...
Osteopore ASX OSX placement

Investors back Osteopore’s expansion plans in $8.5m placement

Advanced bone healing company Osteopore (ASX: OSX) has secured further investor support for its regeneration technology, with the company revealing it had received binding commitments for a $8.5 milli...
Osteopore ASX OSX 3D printed bioresorbable products Queensland University of Technology QUT bone implant

Osteopore to secure bone implant technology from QUT for use in orthopaedic surgeries

Bone healing company Osteopore (ASX: OSX) has signed an exclusive option to licence novel 3D-printed modular bone implant technology being developed by Queensland University of Technology for use in o...
Osteopore distribution agreement Bioplate ASX OSX 3D printed bioresorbable products United States

Osteopore signs first US distribution deal for 3D-printed craniofacial scaffolds

Bone healing biotech company Osteopore (ASX: OSX) has secured an agreement with American cranial bone fixation specialist Bioplate Inc to promote and sell Osteopore products into the US market. It ...
Medical field distributor key decision makers commercialisation Osteopore ASX OSX

Securing best distributor is key to commercialisation in the medical field

A company can create a product that has the ability to change the world, but its commercial success and failure often hinges on how the product enters the market – particularly for complex products li...
3D printed medical material technology COVID-19

COVID-19 prompts increased shift towards 3D printed medical material

With 3D printed material becoming increasingly common in the medical field, the onset of COVID-19 has sparked even further demand for materials made in this revolutionary fashion. Low supplies and ...
Osteopore Australian Therapeutics Goods Administration TGA craniofacial products Osteomesh Osteoplug Osteoplug-C

Osteopore receives TGA approval for 3D-printed medical scaffolds in Australia

Osteopore (ASX: OSX) is now be able to make its 3D-printed medical scaffolds widely available across Australia after its three craniofacial products were approved by the Therapeutic Goods Administrati...
Osteopore 3D-printed bone healing implants sales COVID-19 ASX OSX

Osteopore continues sales momentum despite COVID-19 climate

Biotech company Osteopore (ASX: OSX) is continuing to see strong sales of its 3D-printed ‘bone healing’ implants as its Singaporean manufacturing facility remains fully operational amid COVID-19 conta...
Osteopore revenue China United States ASX OSXvideo

Osteopore boosts revenue, plans to break into Chinese and US markets

Bone healing biotech company Osteopore (ASX: OSX) has posted strong revenue growth since its ASX debut, eyeing China and the US as the next markets for its regenerative technology. The Austra...
Osteopore ASX OSX IPO initial public offering implants bone healing biotech

Osteopore makes ASX debut, plans to become leading producer of 3D-printed implants to promote bone regeneration

Medical technology company Osteopore (ASX: OSX) has made its ASX debut with a $20.2 million market capitalisation following a successful initial public offering which closed early due to strong invest...